Evidence map›Paper›PMID 40374277›Full record

ArticleOpen heart2025

Ratio of interventricular septal thickness to global longitudinal strain accurately identifies cardiac amyloidosis.

Louie Cao, Gloria J Hong, Michael Abiragi, Jonathan Le, P Ryan Tacon, I-Min Chiu, Jignesh Patel, Lily K Stern, Chathuri Daluwatte, David Ouyang and 1 more

Abstract read
In one paragraph

Article in Open heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Imaging Advances in Light Chain Amyloidosis.Diagnostics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Louie CaoCedars-Sinai Medical Center, Los Angeles, California, USA.ORCID 0000-0002-9680-5801
Gloria J HongCedars-Sinai Medical Center, Los Angeles, California, USA.
Michael AbiragiCedars-Sinai Medical Center, Los Angeles, California, USA.
Jonathan LeCedars-Sinai Medical Center, Los Angeles, California, USA.
P Ryan TaconCedars-Sinai Medical Center, Los Angeles, California, USA.
I-Min ChiuCedars-Sinai Medical Center, Los Angeles, California, USA.
Jignesh PatelCedars-Sinai Medical Center, Beverly Hills, California, USA.ORCID 0000-0003-0618-6750
Lily K SternCedars-Sinai Medical Center, Los Angeles, California, USA.
Chathuri DaluwatteAlexion Pharmaceuticals Inc, Boston, Massachusetts, USA.
David OuyangCedars-Sinai Medical Center, Los Angeles, California, USA.
Piero RicchiutoAlexion Pharmaceuticals Inc, Boston, Massachusetts, USA piero.ricchiuto@alexion.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesConventional transthoracic echocardiographic measurements like global longitudinal strain (GLS) have shown promise in distinguishing cardiac amyloidosis (CA), but with limited specificity. We investigated the performance of common echo measurements, GLS, and their combinations in discriminating CA from an undifferentiated cohort with increased left ventricular wall thickness.

methodsWe conducted a retrospective single-centre case-control study of 876 echos from 232 patients with CA and 1325 echos from 279 patients who underwent pyrophosphate scintigraphy but had CA definitively ruled out. Common echo measurements were collected and additional GLS measurements were performed post hoc. We reported discrimination performance with the area under the receiver operating characteristic curve (AUC) and associated sensitivity, specificity and positive predictive value at the optimal threshold.

resultsWe found that the ratio of end-diastolic interventricular septal thickness (IVSd) to GLS had the highest performance in differentiating CA with an AUC of 0.812. At the optimal threshold of >0.15, IVSd/GLS had a sensitivity of 0.70 and specificity of 0.80 for CA. Other measurements and ratios, including the ratio of left ventricular ejection fraction to GLS (AUC 0.682), had lower performance when evaluated against a suspicious control cohort with increased left ventricular wall thickness.

conclusionIf validated in prospective multi-centre studies, the routine measurement of IVSd/GLS can assist with earlier diagnosis of CA, resulting in earlier initiation of treatment in this underserved population.

Indexed as

AmyloidosisCardiomyopathiesEchocardiographyStroke VolumeVentricular Function, LeftVentricular SeptumAgedFemaleGlobal Longitudinal StrainHumansMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsRetrospective StudiesCardiomyopathy, RestrictiveEchocardiographyHeart Failure, Diastolic

Identifiers

PMID40374277
PMCPMC12083331

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.